ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Melanoma in Minutes: Evidence-Driven Care for Improved Patient Outcomes Module 2"
Episode Synopsis
In this concluding module, Michael A. Davies, MD, PhD, University of Texas, MD Anderson Cancer Center, addresses the critical challenges of managing treatment-associated toxicities in the era of advanced melanoma therapies. Discover practical strategies for handling immune-related adverse events, implementing comprehensive supportive care, and optimizing patient education. This podcast is critical for oncology professionals seeking to balance therapeutic efficacy with quality of life for patients receiving cutting-edge immunotherapy and targeted treatments.
Click here to go back and listen to module 1 of this podcast series: https://bit.ly/4iYmYD2
Click here to claim your CME/NCPD credit: https://bit.ly/44yO9RB
Click here to go back and listen to module 1 of this podcast series: https://bit.ly/4iYmYD2
Click here to claim your CME/NCPD credit: https://bit.ly/44yO9RB
More episodes of the podcast Oncology Data Advisor
Optimizing CLL Care: Pharmacist-Led Strategies for Treatment Selection and Toxicity Management
02/10/2025
Esophagogastric Cancer: Enhancing Outcomes Through Biomarkers and Collaborative Care Module 2
11/08/2025
Esophagogastric Cancer: Enhancing Outcomes Through Biomarkers and Collaborative Care - Module 1
11/08/2025
Additional Advances in HER2-Mutated NSCLC With Julia Kathleen Rotow, MD + Activity Module 2
07/08/2025
In God we trust